Saltar al contenido

UCSF Department of Psychiatry and Behavioral Sciences

@ucsfpsych.bsky.social did:plc:td37ll5g4w6nscd22lclr3mt

We are committed to advancing mental health across the lifespan with a mission focused on research, teaching, patient care and public service. linktr.ee/ucsfpsychiatry Social Media Disclaimer: https://psychiatry.ucsf.edu/connect

En Bluesky desde el

Seguidores
231
Siguiendo
48
Posts
467
Días en rankings
0

Resumen

UCSF Department of Psychiatry and Behavioral Sciences (@ucsfpsych.bsky.social) es un usuario de Bluesky que se unió el 21 noviembre 2024. Tiene 231 seguidores, sigue a 48 cuentas y ha publicado 467 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in Pediatrics! Following 11,279 adolescents over 5 years, we found: 🔄 Problematic social media use & depression may reinforce each other 👧 The link was stronger among girls 🔗 tinyurl.com/DepSM26 @ameracadpeds.bsky.social

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    📱 What does the evidence show about policies to protect teens on social media? New in @jamanetworkopen.com: We reviewed 39 publications across 6 policy approaches. 🔗https://tinyurl.com/SMPolicy26

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @ajpmonline.bsky.social! 🧠Adolescents in the low-to-moderate and moderate-to-high problematic social media use trajectories had lower cognitive performance 🔗 Read here: tinyurl.com/socmind @theabcdstudy.bsky.social

    Ver post
  • Jason Nagata, MD@jasonmnagata.bsky.social

    🗣️ New @ucsfchildrens.bsky.social study in @annalsofepi.bsky.social! Among 10,735 adolescents in @theabcdstudy.bsky.social, we found that adolescents with increasing social media use are more likely to experience greater eating disorder symptoms. 🔗 Read here: tinyurl.com/EDTraj

    Ver post
  • UCSF Edward and Pearl Fein Memory and Aging Center@ucsfmac.bsky.social

    Led by Adam Boxer, MD, PhD, and colleagues, UCSF is screening participants for the Alzheimer's Tau Platform (ATP) trial, the first large-scale national study to test combination therapy targeting both amyloid and tau in early or asymptomatic Alzheimer's disease.

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.